Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation
- 1 April 1986
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 111 (4) , 661-666
- https://doi.org/10.1016/0002-8703(86)90095-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Electrophysiologic effects of ethmozin in patients with ventricular tachycardiaAmerican Heart Journal, 1984
- Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: Results of a prospective, controlled trialThe American Journal of Cardiology, 1984
- Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.Circulation, 1984
- Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safetyAmerican Heart Journal, 1983
- High-Performance Liquid Chromatographic Determination of Ethmozin in PlasmaJournal of Pharmaceutical Sciences, 1981
- Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation, 1980
- Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and toleranceAmerican Heart Journal, 1979
- Electrophysiological effects of ethmozin on canine myocardiumCardiovascular Research, 1979
- Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.Circulation, 1978
- Effects of the phenothiazine analog, EN-313, on ventricular arrhythmias in the dogEuropean Journal of Pharmacology, 1977